SCHEMBL4297372

SCHEMBL4297372

CNC(=O)[C@@H](N)CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12519877 1.00
SCHEMBL12852243 1.00
SCHEMBL21134724 0.82 BMP1 (0.43)
SCHEMBL21134870 0.82 BMP1 (0.43)
SCHEMBL11111414 0.81
SCHEMBL10786566 0.81
SCHEMBL1632802 0.80
SCHEMBL8352097 0.79 PTGS1 (0.55)
SCHEMBL21510761 0.79 MMP2 (0.41)
SCHEMBL12534363 0.78 DPP7 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024147125-A1 CYCLOBUTYL-SUBSTITUTED PHENOXY-DIOXETANES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2024-07-11 WO disclosed
WO-2024042313-A1 COMPOUNDS UNIVERSITY OF SOUTHAMPTON (GB) 2024-02-29 WO disclosed
EP-3508476-B1 AMINO MERCAPTAN COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PROTECTION AGAINST RADIATION SHANGHAI KECHOW PHARMA INC (CN) 2023-11-22 EP disclosed
WO-2018026763-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF APTINYX INC. (US) 2018-02-08 WO disclosed
US-9481724-B2 hDC-sign binding peptides THE ROCKEFELLER UNIVERSITY (US) 2016-11-01 US disclosed
US-9050375-B2 Bi-specific digoxigenin binding antibodies HOFFMANN-LA ROCHE, INC. (US) 2015-06-09 US disclosed
US-20150110807-A1 HDC-SIGN BINDING PEPTIDES THE ROCKEFELLER UNIVERSITY (US) 2015-04-23 US disclosed
WO-2015034920-A2 GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR COMPOSITIONS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2015-03-12 WO disclosed
EP-2768971-A1 METHODS FOR THE DETECTION AND THE TREATMENT OF CARDIAC REMODELING Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2014-08-27 EP disclosed
EP-2752424-A1 GLYCOSYLATED POLYPEPTIDE AND DRUG COMPOSITION CONTAINING SAID POLYPEPTIDE Glytech, Inc. (JP) 2014-07-09 EP disclosed
US-20130143251-A1 EXPEDITIOUS SYNTHESIS OF UBIQUITINATED PEPTIDE CONJUGATES BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) 2013-06-06 US disclosed
US-20130143251-A1 EXPEDITIOUS SYNTHESIS OF UBIQUITINATED PEPTIDE CONJUGATES BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) 2013-06-06 US disclosed
WO-2013057313-A1 METHODS FOR THE DETECTION AND THE TREATMENT OF CARDIAC REMODELING INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2013-04-25 WO disclosed
US-20120282280-A1 BI-SPECIFIC DIGOXIGENIN BINDING ANTIBODIES F. HOFFMANN-LA ROCHE AG (CH) 2012-11-08 US disclosed
WO-2011089255-A1 GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY NOVO NORDISK HEALTH CARE AG (CH) 2011-07-28 WO disclosed
US-20100222546-A1 METHODS FOR THE PREPARATION OF FUNCTIONALIZED PEPTIDES, PROTEINS AND CARBOHYDRATES AND THEIR CONJUGATES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-09-02 US disclosed
US-20100081786-A1 Homogeneous Erythropoietin and Other Peptides and Proteins, Methods and Intermediates for Their Preparation NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-04-01 US disclosed
WO-2009156462-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-12-30 WO disclosed
EP-1208116-B1 SOMATOSTATIN ANALOGS, RADIOLABELLED DERIVATIVES THEREOF AND THEIR USE XANTHUS PHARMACEUTICALS INC (US) 2008-04-30 EP disclosed
EP-0488144-A1 Benzodioxole derivatives and hepatopathy improvers comprising the same TSUMURA & CO. (JP) 1992-06-03 EP disclosed